All articles by Rachel Cordery
Rachel Cordery
Deals interview with Mike Preston of Cleary Gottlieb: Oncology is driving healthcare M&As
Pharmaceutical Technology spoke to Mike Preston at top-ten legal adviser Cleary Gottlieb Steen & Hamilton to gain greater insight into the latest trends around M&A in the healthcare industry
Myovant reports uterine fibroid combination therapy results
UK healthcare company Myovant Sciences has announced positive results from LIBERTY 2, its second Phase III study of relugolix combination therapy.